Pfizer posts strong earnings despite Trump’s new 'up to 250%' tariff threat
Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.
Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.
What's Your Reaction?
